Hong Kong Pharma Digital Technology Holdings Ltd

HKPD

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
HKPD
CIK0002007702
SIC5122
SectorWholesale Trade
Industry CategoryWholesale
Industry GroupWholesale – Drugs & Drug Proprietaries

Contact

AddressROOM B1, 5/F. WELL TOWN IND. BUILDING, 13 KO FAI ROAD, YAU TONG, KOWLOON, K3, 00000
Website www.9zt.hk/
Phone(852) 26189289
CEOLap Sun Wong
Employees19

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Is Hong Kong Pharma Digital Technology Holdings Limited's (NASDAQ:HKPD) 36% ROE Better Than Average?

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will...

Article Link

Hong Kong Pharma Digital Technology Holdings Limited Reports Financial Results for the Six Months Ended September 30, 2024

Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ: HKPD) ("HKPD" or the "Company"), a leading provider of over the counter ("OTC") pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced its unaudited financial results for the six months ended September 30, 2024.

Article Link

Hong Kong Pharma Digital Technology Holdings Limited Announces Pricing of Initial Public Offering

Hong Kong Pharma Digital Technology Holdings Limited ("Hong Kong Pharma" or the "Company"), a leading provider of OTC pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced the pricing of its initial public offering (the "Offering") of an aggregate of 1,403,685 ordinary shares of par value $0.001 per share (the "Ordinary Shares"), at a public offering price of US$4.00 per share, of which 1,000,000 Ordinary Shares are offered by Hong Kong Pharma and 403,685 Ord

Article Link

Opening Day: Oilfield services provider Flowco jumps in market debut

Shares of oilfield services provider Flowco jumped in their market debut on Thursday, as they opened for trading 21% above their IPO price. LATEST IPOS AND DIRECT LISTINGS: Flowco (FLOC) opened on January 16 at $29.00. The provider of production optimization, artificial lift and methane abatement solutions for the oil and natural gas industry had priced its initial public offering of 17.8M shares of its Class A common stock at a public offering price of $24.00 per share. PicoCELA (PCLA) opened o

Article Link

Hong Kong Pharma Digital Technology Holdings Limited Announces Closing of Initial Public Offering

Hong Kong Pharma Digital Technology Holdings Limited ("Hong Kong Pharma" or the "Company") (NASDAQ: HKPD), a leading provider of over the counter ("OTC") pharmaceutical cross-border e-commerce supply chain services in Hong Kong, today announced the closing of its initial public offering (the "Offering") of an aggregate of 1,403,685 ordinary shares, par value $0.001 per share (the "Ordinary Shares") at a public offering price of US$4.00 per share of which 1,000,000 Ordinary Shares were offered by

Article Link